Tyra Biosciences (TYRA) Revenue & Revenue Breakdown
Tyra Biosciences Revenue Highlights
Tyra Biosciences Revenue by Period
Tyra Biosciences Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | - |
Tyra Biosciences Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-03-31 | - | -100.00% |
2023-12-31 | $502.00K | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | - |
Tyra Biosciences Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
HOWL | Werewolf Therapeutics | $19.94M | $742.00K |
IKNA | Ikena Oncology | $9.16M | - |
STOK | Stoke Therapeutics | $8.78M | $4.22M |
MOLN | Molecular Partners | $7.04M | $2.74M |
IPSC | Century Therapeutics | $2.23M | $771.00K |
DSGN | Design Therapeutics | - | - |
CGEM | Cullinan Oncology | - | - |
RAPT | RAPT Therapeutics | - | - |
CCCC | C4 Therapeutics | - | - |
GRCL | Gracell Bio | - | - |
PHVS | Pharvaris | - | - |
CNTB | Connect Biopharma | - | - |
ERAS | Erasca | - | - |
PMVP | PMV Pharmaceuticals | - | - |
MLYS | Mineralys Therapeutics | - | - |
GLUE | Monte Rosa Therapeutics | - | $4.70M |
EWTX | Edgewise Therapeutics | - | - |
TYRA | Tyra Biosciences | - | - |
XLO | Xilio Therapeutics | - | $2.36M |
TYRA Revenue FAQ
What is Tyra Biosciences’s yearly revenue?
Tyra Biosciences's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. TYRA's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is Tyra Biosciences’s quarterly revenue?
Tyra Biosciences's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $502K, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022). TYRA's quarterly revenue for Q3 2023 was $0, a 100.00% increase from the previous quarter (Q2 2023), and a 0% increase year-over-year (Q3 2022).
What is Tyra Biosciences’s revenue growth rate?
Tyra Biosciences's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.